Search Results - "Scarffe, J H"

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer by Webb, A, Cunningham, D, Scarffe, J H, Harper, P, Norman, A, Joffe, J K, Hughes, M, Mansi, J, Findlay, M, Hill, A, Oates, J, Nicolson, M, Hickish, T, O'Brien, M, Iveson, T, Watson, M, Underhill, C, Wardley, A, Meehan, M

“…We report the results of a prospectively randomized study that compared the combination of epirubicin, cisplatin, and protracted venous infusion fluorouracil…”
Get more information

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial by WATERS, J. S, NORMAN, A, HILL, A, OATES, J, RAO, S, NICOLSON, M, HICKISH, T, CUNNINGHAM, D, SCARFFE, J. H, WEBB, A, HARPER, P, JOFFE, J. K, MACKEAN, M, MANSI, J, LEAHY, M

“…We report the final results of a prospectively randomized study that compared the combination of epirubicin, cisplatin and protracted venous infusion…”
Get full text

Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma by ROBERTSON, J. D, NAGESH, K, JOWITT, S. N, DOUGAL, M, ANDERSON, H, MUTTON, K, ZAMBON, M, SCARFFE, J. H

“…Vaccination against influenza and Streptococcus pneumoniae is recommended for elderly and immunocompromised individuals. However, there is little information…”
Get full text

Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue by Wardley, A.M., Jayson, G.C., Swindell, R., Morgenstern, G.R., Chang, J., Bloor, R., Fraser, C.J., Scarffe, J.H.

“…Four hundred and twenty‐nine patients received myeloablative chemotherapy for solid and haematological malignancies in a bone marrow transplantation unit…”
Get full text

Extramedullary plasmacytoma of the head and neck region: clinicopathological correlation in 25 cases by SUSNERWALA, S. S, SHANKS, J. H, BANERJEE, S. S, SCARFFE, J. H, FARRINGTON, W. T, SLEVIN, N. J

“…Extramedullary plasmacytomas (EMP) of head and neck are rare tumours. Between 1972 and 1993, 25 cases of EMP of head and neck were seen at our institute. The…”
Get full text

Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients : a randomised, double-blind, placebo-controlled study by KELSEY, S. M, GOLDMAN, J. M, MCCANN, S, NEWLAND, A. C, SCARFFE, J. H, OPPENHEIM, B. A, MUFTI, G. J

“…Liposomal amphotericin (AmBisome) 2 mg/kg three times weekly was compared with placebo as prophylaxis against fungal infection in patients undergoing…”
Get full text

Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD): results of a phase II study by VALLE, J. W, DANGOOR, A, BEECH, J, SHERLOCK, D. J, LEE, S. M, SCARFFE, J. H, SWINDELL, R, RANSON, M

“…Monthly intravenous pegylated liposomal doxorubicin (PLD) 50 mg m(-2), although well tolerated, showed almost no activity in this phase II study of 16 patients…”
Get full text

Peripheral Blood Progenitor Cell Transplantation in Lymphoma and Leukemia Using a Single Apheresis by Pettengell, R., Morgenstern, G.R., Woll, P.J., Chang, J., Rowlands, M., Young, R., Radford, J.A., Scarffe, J.H., Testa, N.G., Crowther, D.

“…Myeloablative treatment and peripheral blood progenitor cell (PBPC) transplantation are increasingly used for lymphomas and leukemias. We have sought to…”
Get full text

Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer by BRONCHUD, M. H, SCARFFE, J. H, THATCHER, N, CROWTHER, D, SOUZA, L. M, ALTON, N. K, TESTA, N. G, DEXTER, T. M

“…Twelve patients with advanced small cell carcinoma of the bronchus were treated by continuous infusion of recombinant human granulocyte colony-stimulating…”
Get full text

Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma by Pettengell, R, Radford, J A, Morgenstern, G R, Scarffe, J H, Harris, M, Woll, P J, Deakin, D P, Ryder, D, Wilkinson, P M, Crowther, D

“…To compare standard and intensive treatment strategies for patients with high-grade non-Hodgkin's lymphoma (NHL) of poor prognosis, defined by the…”
Get more information

PCR-ELISA for the early diagnosis of invasive pulmonary aspergillus infection in neutropenic patients by Jones, M E, Fox, A J, Barnes, A J, Oppenheim, B A, Balagopal, P, Morgenstern, G R, Scarffe, J H

“…AIM: To evaluate a newly developed aspergillus mitochondrial gene PCR-ELISA assay for the early diagnosis of invasive pulmonary aspergillosis (IPA) in…”
Get full text

Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost by LEE, S. M, RADFORD, J. A, DOBSON, L, HUQ, T, RYDER, W. D. J, PETTENGELL, R, MORGENSTERN, G. R, SCARFFE, J. H, CROWTHER, D

“…In order to evaluate the potential clinical and economic benefits of granulocyte colony-stimulating factor (G-CSF, filgrastim) following peripheral blood…”
Get full text

VAD chemotherapy as remission induction for multiple myeloma by ANDERSON, H, SCARFFE, J. H, YOUNG, R, WIERINGA, G. S, MORGENSTERN, G. R, FITZSIMMONS, L, RYDER, D

“…A total of 142 patients with multiple myeloma received VAD as remission induction therapy. Seventy-five were previously untreated and 67 had relapsed (31) or…”
Get full text

Perspectives of commissioners and cancer specialists in prioritising new cancer drugs: impact of the evidence threshold by Foy, Robbie, So, June, Rous, Elizabeth, Scarffe, J Howard

“…Foy et al describe joint experiences in prioritizing drug proposals in 1997-98 for Christie Hospital NHS Trust in Manchester England…”
Get full text

The treatment of nephrotic syndrome caused by primary (light chain) amyloid with vincristine, doxorubicin and dexamethasone by WARDLEY, A. M, JAYSON, G. C, GOLDSMITH, D. J. A, VENNING, M. C, ACKRILL, P, SCARFFE, J. H

“…Three out of four patients with primary (light chain) amyloid nephrotic syndrome treated with vincristine, doxorubicin and dexamethasone (VAD) induction…”
Get full text

Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: A two centre study by Shamash, J., Lee, S. M., Radford, J. A., Rohatiner, A. Z. S., Chang, J., Morgenstern, G. R., Scarffe, J. H., Deakin, D. P., Lister, T. A.

“…Background: High-dose chemotherapy has an established role in recurrent or refractory Hodgkin's lymphoma (HL) although a significant proportion of patients…”
Get full text

Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation by Gisselbrecht, C, Prentice, H G, Bacigalupo, A, Biron, P, Milpied, N, Rubie, H, Cunningham, D, Legros, M, Pico, J L, Linch, D C

“…Haemopoietic growth factors are accepted as accelerating haemopoietic recovery after bone-marrow grafting, yet no large randomised trials have been published…”
Get more information

All‐Trans Retinoic Acid (Atra) and Tranexamic Acid: A Potentially Fatal Combination In Acute Promyelocytic Leukaemia by Brown, J. E., Olujohungbe, A., Chang, J., Ryder, W. D. J., Morganstern, G. R., Chopra, R., Scarffe, J. H.

Get full text

Epidemiology of an outbreak due to glycopeptide-resistant Enterococcus faecium on a leukaemia unit by Chadwick, P.R., Oppenheim, B.A., Fox, A., Woodford, N., Morgenstern, G.R., Scarffe, J.H.

“…The clinical and molecular epidemiology of two clusters of colonization and infection of patients by glycopeptide-resistant enterococci (GRE) on a leukaemia…”
Get full text

In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients by BRONCHUD, M. H, POTTER, M. R, DEXTER, T. M, MORGENSTERN, G, BLASCO, M. J, SCARFFE, J. H, THATCHER, N, CROWTHER, D, SOUZA, L. M, ALTON, N. K, TESTA, N. G

“…Twelve patients with small cell lung cancer were treated with recombinant human granulocyte colony-stimulating factor, rhG-CSF, given by continuous infusion at…”
Get full text